Point72 Hong Kong LTD Akouos, Inc. Transaction History

Point72 Hong Kong LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$2.6 - $5.16 $1,822 - $3,617	701 New	701 $5,000
Q2 2022 Aug 15, 2022	SELL	$2.46 - $5.2 $366 - $774	-149 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.16 - $9.08 $3,777 - $8,244	-908 Reduced 85.9%	149 $1,000
Q4 2021 Feb 14, 2022	BUY	$7.65 - $11.38 $8,086 - $12,028	1,057 New	1,057 $9,000
Q3 2020 Nov 16, 2020	SELL	$19.3 - $26.92 $120,296 - $167,792	-6,233 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$22.0 - $22.5 $137,126 - $140,242	6,233 New	6,233 $140,000

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.